SEHK's August 2024 Stocks That Might Be Undervalued

In This Article:

As global markets react to economic data and shifting investor sentiment, the Hong Kong market has seen its own share of fluctuations. Despite these challenges, opportunities for finding undervalued stocks remain present in the SEHK. In this environment, a good stock often demonstrates strong fundamentals and resilience against broader market volatility.

Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong

Name

Current Price

Fair Value (Est)

Discount (Est)

Best Pacific International Holdings (SEHK:2111)

HK$2.18

HK$4.34

49.7%

Bosideng International Holdings (SEHK:3998)

HK$3.90

HK$6.78

42.5%

ANTA Sports Products (SEHK:2020)

HK$68.80

HK$136.45

49.6%

BYD Electronic (International) (SEHK:285)

HK$28.30

HK$53.03

46.6%

Shanghai INT Medical Instruments (SEHK:1501)

HK$28.20

HK$56.15

49.8%

Pacific Textiles Holdings (SEHK:1382)

HK$1.62

HK$2.99

45.8%

iDreamSky Technology Holdings (SEHK:1119)

HK$2.24

HK$4.22

46.9%

Weimob (SEHK:2013)

HK$1.19

HK$2.18

45.5%

Innovent Biologics (SEHK:1801)

HK$41.15

HK$73.85

44.3%

MicroPort CardioFlow Medtech (SEHK:2160)

HK$0.77

HK$1.38

44.2%

Click here to see the full list of 31 stocks from our Undervalued SEHK Stocks Based On Cash Flows screener.

Let's dive into some prime choices out of the screener.

Pacific Textiles Holdings

Overview: Pacific Textiles Holdings Limited manufactures and trades textile products across various international markets, with a market cap of approximately HK$2.26 billion.

Operations: The company generates HK$4.67 billion in revenue from the manufacturing and trading of textile products.

Estimated Discount To Fair Value: 45.8%

Pacific Textiles Holdings is trading at HK$1.62, significantly below its estimated fair value of HK$2.99, suggesting it may be undervalued based on cash flows. Despite a forecasted annual earnings growth of 37.67%, profit margins have declined from 5.4% to 3.6%. Recent amendments to company bylaws aim to align with regulatory changes, and the proposed final dividend is HKD 0.05 per share for FY2024, despite a notable drop in net income from HKD 268.57 million to HKD 167.12 million year-over-year.

SEHK:1382 Discounted Cash Flow as at Aug 2024
SEHK:1382 Discounted Cash Flow as at Aug 2024

Shanghai INT Medical Instruments

Overview: Shanghai INT Medical Instruments Co., Ltd. (SEHK:1501) operates in the medical instruments sector and has a market cap of HK$4.94 billion.

Operations: The company's revenue from the Cardiovascular Interventional Business is CN¥641.32 million.